Table 1 Patient characteristics
Characteristics | No. of patients | % |
|---|---|---|
Gender | ||
Male | 47 | 58.02 |
Female | 34 | 41.98 |
Age (years) | ||
Median | 61 | |
Range | 44 ~ 82 | |
ECOG PS | ||
0 | 37 | 45.68 |
1 | 44 | 54.32 |
Size of primary tumor(cm) | ||
≥ 5 | 7 | 8.64 |
< 5 | 74 | 91.36 |
Histopathological grading | ||
High | 6 | 7.41 |
Intermediate-high | 5 | 6.17 |
Intermediate | 33 | 40.74 |
Intermediate-low | 24 | 29.63 |
Low | 13 | 16.05 |
TNM stage | ||
I | 45 | 55.56 |
II | 9 | 11.11 |
III | 27 | 33.33 |
Lymph node invasion | ||
Yes | 16 | 19.75 |
No | 65 | 80.25 |
Microvascular invasion | ||
Yes | 17 | 20.99 |
No | 64 | 79.01 |
HBV infection | ||
Yes | 20 | 24.69 |
No | 61 | 75.31 |
HCV infection | ||
Yes | 2 | 2.47 |
No | 79 | 97.53 |
Liver cirrhosis | ||
Yes | 10 | 12.35 |
No | 71 | 87.65 |
Child–Pugh grade | ||
A | 14 | 17.28 |
B | 67 | 82.72 |
CEA (ng/mL) | ||
≥ 10 | 7 | 8.64 |
< 10 | 74 | 91.36 |
CA199(U/mL) | ||
≥ 60 | 62 | 76.54 |
< 60 | 19 | 23.46 |
CA724(U/mL) | ||
≥ 14 | 55 | 67.90 |
< 14 | 26 | 32.10 |
ALT(U/L) | ||
≥ 80 | 56 | 69.14 |
< 80 | 25 | 30.86 |
AST(U/L) | ||
≥ 70 | 50 | 61.73 |
< 70 | 31 | 38.27 |
Total bilirubin(umol/L) | ||
≥ 42 | 69 | 85.19 |
< 42 | 12 | 14.81 |
Direct bilirubin(umol/L) | ||
≥ 16 | 72 | 88.89 |
< 16 | 9 | 11.11 |
Indirect bilirubin(umol/L) | ||
≥ 30 | 49 | 60.49 |
< 30 | 32 | 39.51 |